Cerebrolysin (60 mg Vial)

Reconstitution and handling reference for Cerebrolysin (60 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
Cerebrolysin (60 mg Vial)

Synonyms/Alias: Cerebrolysin

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Reconstitution and handling reference for Cerebrolysin (60 mg Vial). It sets out how much bacteriostatic water to add, what concentration that produces, how the dose maps onto U-100 syringe units, and how the vial should be stored before and after reconstitution.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → 20 mg/mL concentration.

Typical daily range: 20–32 mg once daily (gradual titration); split doses for >20 mg.

Easy measuring: At 20 mg/mL, 1 unit = 0.01 mL = 200 mcg (0.2 mg) on a U‑100 insulin syringe.

Storage: Lyophilized at room temperature ≤25 °C (≤77 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days; do not freeze.

Notes

Practical considerations for consistency and safety. Use new sterile insulin syringes; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation. Inject slowly; wait a few seconds before withdrawing the needle. Document daily dose, timing (AM/PM), and site rotation to maintain consistency. For doses exceeding 100 units (1.0 mL), split into two separate injections at different sites.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Week 1
Daily Dose (mg): 20 mg (20,000 mcg) | Units (per injection) (mL): 100 units (1.0 mL) × 1
Week 2
Daily Dose (mg): 24 mg (24,000 mcg) | Units (per injection) (mL): 60 units (0.6 mL) AM + 60 units (0.6 mL) PM
Week 3
Daily Dose (mg): 28 mg (28,000 mcg) | Units (per injection) (mL): 70 units (0.7 mL) AM + 70 units (0.7 mL) PM
Week 4+
Daily Dose (mg): 32 mg (32,000 mcg) | Units (per injection) (mL): 80 units (0.8 mL) AM + 80 units (0.8 mL) PM
Long-term Storage Conditions
Lyophilized at room temperature ≤25 °C (≤77 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days; do not freeze.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (Cerebrolysin, 60 mg each): 8 weeks ≈ 26 vials

12 weeks ≈ 42 vials

16 weeks ≈ 58 vials

Insulin Syringes (U‑100): Count based on injections per day (1–2 depending on dose). Week 1 (1/day): 7 syringes

Weeks 2–8 (2/day): 98 syringes

8 weeks total: 105 syringes

12 weeks total: 161 syringes

16 weeks total: 217 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (26 vials): 78 mL → 8 × 10 mL bottles

12 weeks (42 vials): 126 mL → 13 × 10 mL bottles

16 weeks (58 vials): 174 mL → 18 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each administration. 8 weeks (105 injections): 210 swabs → recommend 3 × 100‑count boxes

12 weeks (161 injections): 322 swabs → recommend 4 × 100‑count boxes

16 weeks (217 injections): 434 swabs → recommend 5 × 100‑count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China